Genetic Disease Research Branch
Genetic Disease Research Branch (GDRB) investigators study the mechanisms by which genetic changes affect the structure and function of gene products leading to human disease. A major focus for their research lies in understanding how disruptions in signaling pathways and transcription factors contribute to disease.
GDRB investigators use genetics and genomic approaches in both human and mouse systems to identify and better understand pathways involved in human genetic diseases and normal development. Model systems, including genetically altered mice and in vitro cell and organ culture systems, are major components of these investigations. Ongoing efforts include research aimed at understanding genetic contributions to a number of human diseases, particularly those affecting the nervous, immune and musculoskeletal systems. As a major emphasis of their work, GDRB investigators use genetic and genomic tools to understand normal development and differentiation.
Pamela L. Schwartzberg, M.D., Ph.D.
Chief and Senior Investigator, Genetic Disease Research Branch
Head, Cell Signaling and Immunity Section
William J. Pavan, Ph.D.
Senior Investigator, Genetic Disease Research Branch
Head, Genomics, Development and Disease Section
Director, Intramural Training Office
Stacie Loftus, Ph.D.
Associate Investigator, Genetic Disease Research Branch
Brian P. Brooks, M.D., Ph.D.
Director, Ophthalmic Genetics Clinic
Children's National Medical Center
National Eye Institute
Douglas R. Stewart, M.D.
Investigator, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics
National Cancer Institute
Last Updated: December 31, 2014